L-propionyl-carnitine protects tissues from ischaemic injury in an 'in vivo' human ischaemia-reperfusion model

Clinical Drug Investigation

Volumn 22, Issue , 2002, Pages 15-21

  Andreozzi, Giuseppe Maria ^a   Martini, Romeo ^a   Cordova, Rosa Maria ^a   D'Eri, Alessandra ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROPIONYLCARNITINE;

ACIDOSIS; ADULT; AGED; ARTERY BLOOD FLOW; ARTERY DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HYPOXIA; INTERMITTENT CLAUDICATION; ISCHEMIA; MALE; PATIENT MONITORING; POWER SPECTRUM; PRIORITY JOURNAL; REPERFUSION; TISSUE PERFUSION; TRANSCUTANEOUS CARBON DIOXIDE MONITORING; TRANSCUTANEOUS OXYGEN MONITORING;

EID: 0036217443     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200222001-00003     Document Type: Article

References (32)

1. Muscle carnitine deficiency in patients with severe peripheral vascular disease
2. Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease
3. Carnitine deficiency of skeletal muscle: Report of a treated case
4. Possible causes and effects of carnitine deficiency in man
5. Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: An acute, intravenous, double-blind, cross-over study
6. Propionyl-L-carnitine in intermittent claudication: Double-blind, placebo-controlled, dose titration, multicenter study
7. European multicenter study on propionyl-L-carnitine in intermittent claudication
8. Current and future drug therapies for claudication
9. Management of peripheral arterial disease
10. Anaplerotic effect of propionyl carnitine in rat heart mitochondria
11. Pyruvate-dehydrogenase complex: Meticulous regulator of glucose disposal in animals
12. Possible functions of short chain and medium-chain carnitine acyltransferase
13. Increase in walking distance in patients with peripheral vascular disease treated with L-carnitine: A double-blind, cross-over study
14. Oxygen transcutaneous tensiometry (TcPO2) for micro-circulatory evaluation of peripheral arterial diseases
15. Flow dynamics and pathophysiological mechanisms of diseases of lower limb arteries
16. The leucocytic chemotaxis and the malondialdehide
17. La misura della TcPO2 e della TcPCO2 nella valutazione funzionale delle arteriopatie periferiche
18. Evaluation of postischaemic hyperemia on the skin using laser Doppler velocimetry: Study on patients with claudicatio intermittens
19. Laser Doppler
20. The frequency histogram: A new method for the evaluation of laser Doppler flux motion
21. Analysis of laser Doppler flux motion in man: Comparison of autoregressive modelling and fast Fourier transformation
22. Variations of rhythmical diameter changes at the arterial microvascular bifurcation
23. Vasomotion as a normal microvascular activity and reaction to impaired homeostasis
24. La microcircolazione quale fattore determinante della fase di compenso o di non compenso delle vasculopatie
25. The assessment of the skin necrosis risk in the critical legs ischaemia
26. Dynamic measurement and functional assessment of TcPO2 and TcPCO2 in the peripheral arterial disease
27. Could the severe claudication be classified in the critical leg ischaemia?
28. Transcutaneous pCO2 as an index of tissue resistance to ischaemia
29. Iloprost, stable analogue of the prostacyclin, is able to improve the tissue resistance to ischaemia
30. Metabolic effects induced by L-carnitine and propionyl-L-carnitine in human hypoxic muscle tissue during exercise
31. Propionyl-L-carnitine effects on the microcirculation in experimental animal models